Returns | 1W : 2.1% , 1M : -2%,1Y : 18.9% |
LT :   |
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap] Debt : Low |
ST :   |
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Peers & Returns | 1W | 1M | 1Y |
SUN PHARMA ADVANCED RESEARCH COMPANY | 2.1% | -2% | 18.9% |
SYNGENE INTERNATIONAL | 8.4% | 12% | 110.4% |
QUESS CORP | -8.6% | -20.2% | 184.4% |
SECURITY AND INTELLIGENCE SERVICES INDIA | -1.3% | -11.7% | -5.2% |
TEAMLEASE SERVICES | -8.5% | -10.7% | 105% |
DELTA CORP | -5.6% | -23.2% | 118.7% |
JUST DIAL | 0.9% | -3.9% | 160.1% |
HEALTHCARE GLOBAL ENTERPRISES | -0.3% | -5.9% | 145.7% |
FERMENTA BIOTECH | 17.2% | 6.1% | 8.3% |
Ratio | Value |
---|---|
P/E P/B P/S |
-
P/E Calculated based on EPS of -11.92
[ Mar2020 - Standalone Results ] -
P/B Calculated based on Book Value of -0.71
[ Mar2020 - Standalone Results ] 17.08
P/S Calculated based on Revenues of 244.95 Cr
[ TTM - Standalone Results ] |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA -59% -60% |
Pledged Shares |
1.9 % |
---|---|
As on : Sep2020 | |
If less than 25% | Good |
If between 25% and 50% | Neutral |
If greater than 50% | Bad |
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 2.5% | 9.5% | 53.4% |
S&P BSE 400 MIDSMALLCAP | 0.6% | -3.4% | 88.9% |
S&P BSE MIDSMALLCAP | 0.6% | -2.9% | 87.1% |
S&P BSE SMALL CAP | 0.6% | -2.3% | 99.4% |
S&P BSE ALLCAP | 0.5% | -3.5% | 67.3% |
S&P BSE 500 | 0.5% | -3.5% | 66.4% |
S&P BSE 250 SMALLCAP | -0.2% | -4.9% | 97.8% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 | 0.4% | -3.5% | 65.9% |
NIFTY MID SMALL400 | 0.4% | -3.6% | 89.2% |
NIFTY SMALLCAP250 | 0.2% | -4.1% | 100.5% |
NIFTY SMALLCAP 50 | -0% | -5.2% | 118.1% |
NIFTY FREE SMALL 100 | -0.2% | -4.5% | 108.8% |